111 related articles for article (PubMed ID: 5569050)
1. The effects of clofibrate on acetyl-CoA carboxylase activity in hepatocytes.
Harkins JB; Yates RD
Z Zellforsch Mikrosk Anat; 1971; 119(3):321-5. PubMed ID: 5569050
[No Abstract] [Full Text] [Related]
2. Effect of clofibrate (ethyl-chlorophenoxyisobutyrate) feeding on glycolytic and lipogenic enzymes and hepatic glycogen synthesis in the rat.
Zakim D; Paradini RS; Herman RH
Biochem Pharmacol; 1970 Jan; 19(1):305-10. PubMed ID: 5507646
[No Abstract] [Full Text] [Related]
3. Rat hepatocyte peroxisomes: ultrastructural alterations following cessation of chronic dietary clofibrate administration.
Hartman HA; Tousimis AJ
Experientia; 1969 Dec; 25(12):1248-9. PubMed ID: 5365841
[No Abstract] [Full Text] [Related]
4. Effects of selected hypolipidemic drugs on cell ultrastructure.
Svoboda DJ; Azarnoff DL
Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
[No Abstract] [Full Text] [Related]
5. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
Azarnoff DL; Svoboda DJ
Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540
[No Abstract] [Full Text] [Related]
6. Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.
Reddy J; Svoboda D
Am J Pathol; 1971 Apr; 63(1):99-108. PubMed ID: 4323477
[No Abstract] [Full Text] [Related]
7. [Depression of rat liver acetyl-CoA-carboxylase activity by salicylate and other compounds].
Denisenko TV; Poliakova ED
Vopr Med Khim; 1977; 23(5):667-72. PubMed ID: 22955
[TBL] [Abstract][Full Text] [Related]
8. Effect of clofibrate on plasma lipids of rat and rabbit.
Byers SO; Friedman M
Atherosclerosis; 1970; 11(3):373-82. PubMed ID: 5433083
[No Abstract] [Full Text] [Related]
9. Stimulation of liver catalase synthesis in rats by ethyl-alpha-p-chlorophenoxyisobutyrate.
Reddy J; Chiga M; Svoboda D
Biochem Biophys Res Commun; 1971 Apr; 43(2):318-24. PubMed ID: 4996023
[No Abstract] [Full Text] [Related]
10. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
[No Abstract] [Full Text] [Related]
11. New observations on microbodies. A cytochemical study on CPIB-treated rat liver.
Legg PG; Wood RL
J Cell Biol; 1970 Apr; 45(1):118-29. PubMed ID: 5458991
[TBL] [Abstract][Full Text] [Related]
12. The effect of clofibrate on rat tissue adenyl cyclase.
Greene HL; Herman RH; Zakim D
Proc Soc Exp Biol Med; 1970 Sep; 134(4):1035-8. PubMed ID: 4318660
[No Abstract] [Full Text] [Related]
13. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
White LW
J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
[No Abstract] [Full Text] [Related]
14. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
Kokatnur MG; Malcom GT
Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
[No Abstract] [Full Text] [Related]
15. Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandox 42-348) on steroid and drug metabolism by rat liver microsomes.
Salvador RA; Haber S; Atkins C; Gommi BW; Welch RM
Life Sci; 1970 Apr; 9(7):397-407. PubMed ID: 5445848
[No Abstract] [Full Text] [Related]
16. The effect of clofibrate on spontaneous arteriosclerosis in rats.
Tucker MJ
Atherosclerosis; 1971; 13(2):255-65. PubMed ID: 4254399
[No Abstract] [Full Text] [Related]
17. Ethanol metabolism in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate).
Kähönen MT; Ylikahri RH; Hassinen I
Life Sci II; 1971 Jun; 10(12):661-70. PubMed ID: 5560535
[No Abstract] [Full Text] [Related]
18. Differential effect of clofibrate on acetyl-CoA carboxylase mRNA level in rat white and brown adipose tissue.
Karbowska J; Kochan Z; Swierczyński J
Life Sci; 2000; 66(6):545-52. PubMed ID: 10794071
[TBL] [Abstract][Full Text] [Related]
19. Effect of atromid-S and high fat diet on lipid contents and lipolysis in rat tissues and serum.
Grafnetter D; Mrhová O; Janda J
Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):159-73. PubMed ID: 5551199
[No Abstract] [Full Text] [Related]
20. The effect of MK-185 on some aspects of uric acid metabolism.
Jain A; Ryan JR; Hague D; McMahon FG
Clin Pharmacol Ther; 1970; 11(4):551-7. PubMed ID: 5429180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
